Sio Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Sio Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-526,239	Closed	-$2.21M	–	61
2023 Q1	$2.21M	Buy	526,239 +196,239	+59%	+$1.02M	1.09%	19
2022 Q4	$1.98M	Buy	+330,000	New	+$1.8M	0.73%	23
2016 Q1	–	Sell	-529,226	Closed	-$6.51M	–	60
2015 Q4	$6.51M	Buy	+529,226	New	+$7.07M	2.88%	11
2015 Q1	–	Sell	-50,500	Closed	-$1.19M	–	45
2014 Q4	$1.19M	Buy	+50,500	New	+$1.17M	0.94%	26

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Sio Capital Management's CTIC Position: Q2 2023 in Review

Sio Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 526,239 shares — an estimated $2.21M sold.

Sio Capital Management first reported a position in CTIC in Q4 2014 and held it in 4 quarters. The position peaked at $6.51M in Q4 2015. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Sio Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Sio Capital Management sold 526,239 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $2.21M.
Sio Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2014 and held it in 4 quarters.
Sio Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $6.51M in Q4 2015.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Sio Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.